Switching to treatment with recombinant factor VIII Fc fusion protein: extended dosing interval yields low bleeding rates with comparable factor consumption and is correlated with von Willebrand Factor levelsJohannes Oldenberg,Amy D. Shapiro,Margaret V. Ragni,Roshni Kulkarni,Alok Srivastava,Doris V. Quon,K. John Pasi,Hideji Hanabusa,Ingrid Pabinger,Johnny Mahlangu,Patrick Fogarty,David Lillicrap,Sarah Kulke,James Potts,Srividya Neelakantan,Ivan Nestorov,Shuanglian Li,Jennifer A. Dumont,Haiyan Jiang,Aoife Brennan,Glenn F. PierceHAEMOPHILIA（2014）引用 0|浏览7暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
